Sawaya Segalas is widely recognized for its expertise in providing independent and thoughtful advice to consumer industry companies, management and boards of directors. Furthermore, our firm does not trade or underwrite securities, act as a lender, or publish research on publicly traded securities. As a result, we are in a position to offer our clients truly unbiased advice regarding strategic and financing alternatives.
 
Handstands  
Handstands
Household Products & DIY | Buy-Side | General Advisory | Private Equity
Brand: California Scents
Owner/Parent: Trivest
Counterparty: California Scents
Transaction Value: Undisclosed
Closing Date: September 2, 2015
Role: Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Corporate Divestiture | General Advisory |
Public Company
Brand: Bonine
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: WellSpring Pharmaceutical Corp., Sentinel Capital Partners
Transaction Value: Undisclosed
Closing Date: September 3, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Public Company
Brands: Monistat, EPT, and Nix among others
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Insight Pharmaceuticals, LLC., Swander Pace Capital
Transaction Value: $750.0 million
Closing Date: September 3, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News      arrow  View Investor Call
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Brand: Hydralyte
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Hydration Pharmaceuticals Trust of Victoria, Australia
Transaction Value: $50.0 million (AUD)
Closing Date: May 1, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Brand: Care Pharmaceuticals
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Care Pharmaceuticals
Transaction Value: Undisclosed
Closing Date: July 1, 2013
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: Debrox®, Gly-Oxide®
Transaction Value: $45.0 million
Closing Date: April 2, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: BC®, Goody's®, Ecotrin®, Beano®, Gaviscon®, Phazyme®, Tagamet®, Fiber Choice®, GI Brands and Sominex® among others
Transaction Value: $615.0 million
Closing Date: January 31, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News      arrow  View Investor Presentation
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Public Company
Counterparty: McNeil-PPC, Inc.
Brand: Dramamine
Transaction Value: $76.0 million
Closing Date: January 6, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Kaz, Incorporated  
Kaz, Incorporated
Personal Care, OTC & Cosmetics | Housewares | Sell-Side | General Advisory | Family Business
Brands: Honeywell, Vicks, Braun
Counterparty: Helen of Troy Limited
Transaction Value: $260.0 million
Closing Date: December 31, 2010
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News       arrow  View Investor Presentation
 
Beiersdorf AG  
Beiersdorf AG
Personal Care, OTC & Cosmetics | Corporate Divestiture | General Advisory | Public Company
Brand: Curad
Counterparty: Medline Industries, Inc.
Transaction Value: Undisclosed
Closing Date: April 27, 2007
Role: Exclusive Financial Advisor
View Case Study  arrow  View Case Study View Related News  arrow  View Related News